7noVaccines are so far proven to be safe, although related adverse events cannot be excluded. The urgency for COVID-19 vaccines determined a dilution of the general expectations of safety and efficacy of vaccination (from safe and effective to safe and effective enough). In many countries, a no-fault program was established to compensate individuals who experienced serious vaccine-related injuries. The impressive number of administrations worldwide and the legal indemnity afforded to manufacturers of approved vaccines that cannot be pursued for compensation fed the debate about the availability of a compensation model for COVID-19 vaccine-related injuries. Several European countries have long introduced a system, Vaccine Injury Compensation...
International audienceIn this article, the author explains the principle of compensation in the even...
The European Convention on Human Rights (ECHR) judgement no. 116(2021) of 8 April 2021 establishes t...
The article aims to elaborate on European policy choices for the prevention of SARS-CoV-2 contagion,...
Vaccines are so far proven to be safe, although related adverse events cannot be excluded. The urgen...
Italy, like other European countries, has produced a series of regulations during the COVID-19 pande...
Italy, like other European countries, has produced a series of regulations during the COVID-19 pande...
The introduction of a compulsory vaccination regime makes it possible to fight against viruses and p...
Abstract: Compensation for damage caused to patients by vaccination is an increasingly prominent is...
The COVID-19 vaccination has proven to be the most effective prevention measure, reducing deaths and...
Adverse physical reactions to immunizations, 1 although comparatively rare, raise fundamental questi...
Policy & practice Abstract Programmes that provide no-fault compensation for an adverse event fo...
ABSTRACT This work aims at exploring the remedies provided in the Italian legal system in favor of ...
• The development and eventual deployment of an Ebola vaccine was delayed for various technical and ...
This is a briefing paper on behalf of a group of specialists drawn from different disciplines settin...
The global rollout of COVID-19 vaccines is underway, and with it the inevitable occurrence of severe...
International audienceIn this article, the author explains the principle of compensation in the even...
The European Convention on Human Rights (ECHR) judgement no. 116(2021) of 8 April 2021 establishes t...
The article aims to elaborate on European policy choices for the prevention of SARS-CoV-2 contagion,...
Vaccines are so far proven to be safe, although related adverse events cannot be excluded. The urgen...
Italy, like other European countries, has produced a series of regulations during the COVID-19 pande...
Italy, like other European countries, has produced a series of regulations during the COVID-19 pande...
The introduction of a compulsory vaccination regime makes it possible to fight against viruses and p...
Abstract: Compensation for damage caused to patients by vaccination is an increasingly prominent is...
The COVID-19 vaccination has proven to be the most effective prevention measure, reducing deaths and...
Adverse physical reactions to immunizations, 1 although comparatively rare, raise fundamental questi...
Policy & practice Abstract Programmes that provide no-fault compensation for an adverse event fo...
ABSTRACT This work aims at exploring the remedies provided in the Italian legal system in favor of ...
• The development and eventual deployment of an Ebola vaccine was delayed for various technical and ...
This is a briefing paper on behalf of a group of specialists drawn from different disciplines settin...
The global rollout of COVID-19 vaccines is underway, and with it the inevitable occurrence of severe...
International audienceIn this article, the author explains the principle of compensation in the even...
The European Convention on Human Rights (ECHR) judgement no. 116(2021) of 8 April 2021 establishes t...
The article aims to elaborate on European policy choices for the prevention of SARS-CoV-2 contagion,...